目的 基于文献计量学方法探讨中医药防治肌少症领域的研究现状、前沿热点与发展趋势，为该病的临床防治及机制研究提供数据参考。方法 检索2007年1月—2025年12月中国学术期刊全文数据库（CNKI）、万方（Wanfang）、维普数据库（VIP）、Web of Science、PubMed数据库中中医药干预肌少症的相关文献，运用WPS 12.1.0.26895、CiteSpace 6.4.R1、VOSviewer 1.6.20软件，对文献发文趋势、核心作者、研究机构、刊载期刊及关键词共现、聚类、时间线、突现特征开展系统性计量分析。结果 最终纳入有效中文文献440篇、英文文献100篇。发文趋势分析显示，2021年后该领域中、英文发文量均呈快速攀升趋势；高产核心作者分别为中文领域元唯安、英文领域Zhang Jing（张晶），核心研究机构分别为辽宁中医药大学、成都中医药大学（Chengdu University of Traditional Chinese Medicine）。关键词热点分析表明，中文研究聚焦肌少症中医证候辨识、治则治法、合并疾病及中药复方、传统运动干预等临床应用研究；英文研究侧重作用机制解析、天然活性成分干预及随机对照试验等循证医学评价。结论 目前中医药防治肌少症研究仍处于初步发展阶段，研究团队与机构间学术协作不足，领域国际影响力有待进一步提升。未来需强化跨机构、跨区域学术交流与合作，推动中医药在肌少症领域的应用与发展。

Objective To explore the current research status, emerging trends, and development directions in the field of traditional Chinese medicine (TCM) for the prevention and treatment of sarcopenia using bibliometric methods, providing data support for clinical management and mechanistic studies. Methods Relevant literature on TCM interventions for sarcopenia was retrieved from China National Knowledge Infrastructure, Wanfang, VIP, Web of Science, and PubMed from January 2007 to December 2025. Systematic bibliometric analysis was conducted using WPS 12.1.0.26895, CiteSpace 6.4.R1, and VOSviewer 1.6.20 to examine publication trends, core authors, research institutions, journals, keyword co-occurrence, clustering, timeline, and burst detection. Results A total of 440 Chinese articles and 100 English articles were included. Publication trend analysis revealed a rapid increase in both Chinese and English publications after 2021. The top productive authors were Yuan Wei’an in Chinese literature and Zhang Jing in English literature, while the leading research institutions were Liaoning University of Traditional Chinese Medicine and Chengdu University of Traditional Chinese Medicine. Keyword analysis indicated that Chinese studies focused on TCM syndrome differentiation, therapeutic principles and methods, comorbidities, herbal formulae, and traditional exercise interventions; English studies emphasized mechanism exploration, intervention with natural active compounds, and evidence-based evaluations such as randomized controlled trials. Conclusion Research on TCM for sarcopenia remains in an early developmental stage, with insufficient academic collaboration among research teams and institutions, and limited international influence. Future efforts should strengthen cross-institutional and cross-regional academic exchange and cooperation to promote the application and advancement of TCM in sarcopenia research.

R242

国家自然科学基金青年项目（82405058）；山西省基础研究计划青年项目（202403021212248）；山西中医药大学优秀博士毕业生来晋工作奖励经费科研启动基金项目（2024BKS01）；山西中医药大学杏林英才计划（2025XK11）；山西中医药大学博士科研启动基金（2024BK05）；山西中医药大学科技创新能力培育计划“基础与临床合作研究专项”（2025PY-JL-28-01）；山西省中医药科技创新工程项目（2024kjzy002）；中药生命组学与创新药物研发研究室（zyyyjs2024019）